Cite
APA Citation
Filizoglu, N., Ozguven, S., & Erdil, T. Y. (2022). 18F-FDG PET/CT Metabolic Response With Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Breast Cancer Treated With Cyclin-Dependent 4/6 Kinase Inhibitors. Clinical nuclear medicine, 47, e605–e606. http://access.bl.uk/ark:/81055/vdc_100161163628.0x000019